Biohaven Pharmaceutical Holding Co Ltd.(BHVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BHVN Biohaven Pharmaceutical Holding Co Ltd.

Not Yet Opened 01-22 16:00:00 EST

13.76

+0.89

+6.92%

盘后13.56

-0.20-1.45%

19:27 EST

High13.79	Low12.70	Vol2.81M
Open13.00	D1 Closing12.87	Amplitude8.47%
Mkt Cap1.83B	Tradable Cap1.54B	Total Shares132.64M
T/O38.12M	T/O Rate2.51%	Tradable Shares112.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BHVN","market":"US","secType":"STK","nameCN":"Biohaven Pharmaceutical Holding Co Ltd.","latestPrice":13.76,"timestamp":1769115600000,"preClose":12.87,"halted":0,"volume":2810745,"hourTrading":{"tag":"盘后","latestPrice":13.56,"preClose":13.76,"latestTime":"19:27 EST","volume":61715,"amount":848910.66,"timestamp":1769128036888,"change":-0.2,"changeRate":-0.014535,"amplitude":0.018895},"delay":0,"changeRate":0.06915306915306921,"floatShares":112000000,"shares":132637000,"eps":-7.586766,"marketStatus":"Not Yet Opened","change":0.89,"latestTime":"01-22 16:00:00 EST","open":13,"high":13.79,"low":12.7,"amount":38122589.77569,"amplitude":0.084693,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.586766,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1769158800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1493870400000,"exchange":"NYSE","adjPreClose":12.87,"preHourTrading":{"tag":"盘前","latestPrice":13.19,"preClose":12.87,"latestTime":"09:11 EST","volume":1328,"amount":17569.555536,"timestamp":1769091103654,"change":0.32,"changeRate":0.024864,"amplitude":0.039627},"postHourTrading":{"tag":"盘后","latestPrice":13.56,"preClose":13.76,"latestTime":"19:27 EST","volume":61715,"amount":848910.66,"timestamp":1769128036888,"change":-0.2,"changeRate":-0.014535,"amplitude":0.018895},"volumeRatio":0.827349,"impliedVol":0.7864,"impliedVolPercentile":0.1833},"requestUrl":"/m/hq/s/BHVN/tweets","defaultTab":"tweets","newsList":[{"id":"2605913480","title":"Biohaven Shares Rise After RBC Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2605913480","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605913480?lang=en_us&edition=fundamental","pubTime":"2026-01-22 03:54","pubTimestamp":1769025253,"startTime":"0","endTime":"0","summary":"Biohaven  shares were up about 3% in recent Wednesday trading after RBC upgraded the biopharmaceutical firm's stock to outperform from sector perform and raised its price target to $22 from $9.Trading volume stood at more than 2.18 million shares, compared with a daily average of over 4.23 million.Price: 13.06, Change: +0.38, Percent Change: +2.96","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU1093756325.SGD","LU1093756168.USD","BHVN"],"gpt_icon":0},{"id":"2605835014","title":"Biohaven Shares up 6.3% After RBC Raises to 'Outperform'","url":"https://stock-news.laohu8.com/highlight/detail?id=2605835014","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605835014?lang=en_us&edition=fundamental","pubTime":"2026-01-21 22:33","pubTimestamp":1769005994,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YM0QJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1093756325.SGD","LU1093756168.USD","BK4139","BHVN"],"gpt_icon":0},{"id":"2605106527","title":"RBC Upgrades Biohaven to Outperform From Sector Perform, Boosts Price Target to $22 From $9, Keeps Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2605106527","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605106527?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:17","pubTimestamp":1768994255,"startTime":"0","endTime":"0","summary":"Biohaven (BHVN) has an average rating of overweight and mean price target of $20.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756325.SGD","BK4139","LU1093756168.USD","BHVN"],"gpt_icon":0},{"id":"2605106849","title":"Biohaven Shares up 6% Premarket After RBC Raises to Outperform From Sector Perform","url":"https://stock-news.laohu8.com/highlight/detail?id=2605106849","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605106849?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:10","pubTimestamp":1768993853,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nL4N3YM0YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BHVN","LU1093756325.SGD","LU1093756168.USD"],"gpt_icon":0},{"id":"2605748201","title":"U.S. RESEARCH ROUNDUP-IBM, KLA, WEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2605748201","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605748201?lang=en_us&edition=fundamental","pubTime":"2026-01-21 16:26","pubTimestamp":1768984001,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-IBM, KLA, WEXJan 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including IBM, KLA and WEX, on Wednesday","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nL4N3YM0NJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AR","ABM","APG","ARCB","BEAM","AZN","ARES","BRBR","ARDX","AU","CRI","BA","AMP","ASGN","ACLS","KMX","AMDL","ACM","AMD","AMDY","CPB","ALGM","GGLL","AN","APLD","AMYY","AXSM","BKR","APLS","DAMD","AMDW","BG","AMDG","ACVA","AMDD","ARWR","AMUU","BOKF","EAT","AMDU","GOOGL","MMM","ADI","AME","BFAM","ABG","ALB","APD","BHVN","CZR"],"gpt_icon":1},{"id":"2603622805","title":"Biohaven (BHVN) Stock Is Trending Overnight — Here's What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2603622805","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603622805?lang=en_us&edition=fundamental","pubTime":"2026-01-15 10:48","pubTimestamp":1768445280,"startTime":"0","endTime":"0","summary":"Biohaven Ltd. shares surged 3.42% in after-hours trading following an SEC filing that detailed investor presentations and updates on its drug pipeline.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/14/Stock-Market-Analysis-With-Candlestick-C.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/14/Stock-Market-Analysis-With-Candlestick-C.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/01/49925544/biohaven-bhvn-stock-is-trending-overnight-heres-what-you-should-know","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/01/49925544/biohaven-bhvn-stock-is-trending-overnight-heres-what-you-should-know","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["RSI","BK4150","BK4139","LU1093756325.SGD","LU1093756168.USD","BHVN"],"gpt_icon":0},{"id":"2603542729","title":"Biohaven Provides Updates on Several Clinical Programs; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2603542729","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603542729?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:57","pubTimestamp":1768237072,"startTime":"0","endTime":"0","summary":"Biohaven  said Monday that it is \"positioned to achieve significant milestones\" in 2026 as it provided updates on several of its clinical programs.Regarding its IgA nephropathy program, the company said it completed a meeting with the US Food and Drug Administration in Q4 2025 to align its study design and expects to begin the trial in early 2026.The company said that it is planning a study evaluating BHV-1300 in Graves' disease, an autoimmune condition, this year.Biohaven announced preliminary data in a study evaluating opakalim in an ongoing open-label extension study in focal epilepsy, and said pivotal results from the trial are expected this year.Regarding its obesity study, the company said it began dosing patients in a phase 2 trial with its myostatin-activin inhibitor for weight loss in Q4 2025, with topline results expected this year.The company also provided updates on its studies related to cancer, Parkinson's disease, and others.Biohaven shares were up 10% in recent Monday t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756325.SGD","LU1093756168.USD","BHVN","BK4139"],"gpt_icon":0},{"id":"2603542518","title":"Biohaven reports ‘positive’ early experience from Priority Degrader Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2603542518","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603542518?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:20","pubTimestamp":1768234817,"startTime":"0","endTime":"0","summary":"Biohaven (BHVN) highlighted its “broad portfolio progress” at the 44th Annual J.P. Morgan Healthcare Conference, the company reported. Vlad Coric, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biohaven-reports-positive-early-experience-from-priority-degrader-programs-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biohaven-reports-positive-early-experience-from-priority-degrader-programs-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ1G4Q59.USD","LU1989772840.SGD","LU1548497426.USD","LU0314104364.USD","LU1244550494.USD","LU1363072403.SGD","LU1162221912.USD","LU0158827948.USD","LU1668664300.SGD","BHVN","LU0098860793.USD","LU0158827781.USD","IE00BKVL7J92.USD","LU2111349929.HKD","BK4585","LU0557290698.USD","LU1244550221.USD","BK4581","LU1244550577.SGD","LU0795875086.SGD","LU1791710582.SGD","LABU","LU1732800096.USD","LU2089284900.SGD","LU0234570918.USD","LU1989772923.USD","LU0971096721.USD","XBI","BK4516","LU2357305700.SGD","BK4534","LU1074936037.SGD","LU2023251221.USD","LU2089283258.USD","LU2133065610.SGD","XLV","LU0106261372.USD","LU2028103732.USD","LU2271345857.HKD","LU0912757837.SGD","BK4139","BK4127","LU0225283273.USD","LU1720051108.HKD","LU1732799900.SGD","LU0106831901.USD","LU0882574139.USD","LU1093756168.USD","LU1093756325.SGD","LU1720051017.SGD"],"gpt_icon":0},{"id":"2603544288","title":"Biohaven Showcases Breakthrough Degrader Platforms at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2603544288","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603544288?lang=en_us&edition=fundamental","pubTime":"2026-01-13 00:15","pubTimestamp":1768234518,"startTime":"0","endTime":"0","summary":"Biohaven Ltd. presented updates on its portfolio progress and early patient data from its priority degrader programs at the 44th Annual J.P. Morgan Healthcare Conference. The company highlighted positive early clinical experience with its proprietary MoDE and next-generation TRAP degraders, which showed rapid removal of circulating disease-causing proteins and robust clinical improvement in patients. Biohaven also announced a memorandum of understanding with King Abdullah University of Science and Technology  to collaborate on next-generation degrader discovery efforts.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biohaven Ltd. published the original content used to generate this news brief via PR Newswire  on January 12, 2026, and i","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL21GYXY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHVN","LU1093756325.SGD","BK4139","LU1093756168.USD"],"gpt_icon":0},{"id":"2601465816","title":"Biohaven Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2601465816","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601465816?lang=en_us&edition=fundamental","pubTime":"2026-01-06 23:36","pubTimestamp":1767713760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BHVN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 06, 2026 10:36 ET (15:36 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1093756168.USD","BHVN","LU1093756325.SGD"],"gpt_icon":0},{"id":"2594297481","title":"Biohaven Shares Pare Losses; Last up 0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594297481","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594297481?lang=en_us&edition=fundamental","pubTime":"2025-12-27 00:54","pubTimestamp":1766768061,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251226:nL4N3XW0KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1093756325.SGD","LU1093756168.USD","BK4139","BHVN"],"gpt_icon":0},{"id":"2594297111","title":"Biohaven's Epilepsy Opportunity Seen Outshining Depression Trial -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2594297111","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594297111?lang=en_us&edition=fundamental","pubTime":"2025-12-27 00:47","pubTimestamp":1766767620,"startTime":"0","endTime":"0","summary":"11:47 ET - Biohaven still has strong potential despite a Phase 2 study of BHV-7000 not meeting its primary endpoint to treat depression, Raymond James analysts say. The analysts continue to rate the stock as a strong buy because they are focused on Biohaven's plans to develop BHV-7000 to treat epilepsy. BHV-7000 has a lot of promise as an epilepsy treatment, including a potentially best-in-class safety profile compared with competitor azetukalner, the analysts say. Biohaven plans to share data in January and have its first pivotal readout for epilepsy in the first half of 2026, which the analysts think will boost its near-term value. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d018407bd33f27ba9ab8988ad29e6a0c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BHVN","LU1093756168.USD","BK4139"],"gpt_icon":0},{"id":"2594294017","title":"US Stocks Mixed; Biohaven Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2594294017","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594294017?lang=en_us&edition=fundamental","pubTime":"2025-12-26 22:45","pubTimestamp":1766760300,"startTime":"0","endTime":"0","summary":"U.S. stocks traded mixed this morning, with the Dow Jones index falling around 0.1% on Friday.Following the market opening Friday, the Dow traded down 0.07% to 48,698.11 while the NASDAQ rose 0.12% to 23,641.67. The S&P 500 also rose, gaining, 0.11% to 6,939.71.Check This Out: Top 2 Utilities Stocks That Could Lead To Your Biggest Gains This Month. Leading and Lagging SectorsInformation technology shares rose by 0.4% on Friday.In trading on Friday, industrials stocks fell by 0.2%.Shares of Biohaven Ltd.  fell on Friday after the company reported results from a Phase 2 proof-of-concept study evaluating BHV-7000 for major depressive disorder .The study did not meet its primary endpoint, a reduction of depressive symptoms as measured by change in the Montgomery sberg Depression Rating Scale  over six weeks compared with placebo.Asian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 0.68%, China's Shanghai Composite rising 0.10% and India's BSE Sensex falling 0.43%.No major ","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/26/Tallinn--Estonia---August-4th-2023---Scr.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/26/Tallinn--Estonia---August-4th-2023---Scr.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/market-summary/25/12/49593341/us-stocks-mixed-biohaven-shares-fall","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/12/49593341/us-stocks-mixed-biohaven-shares-fall","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","LU1093756168.USD","LU1093756325.SGD","BHVN"],"gpt_icon":0},{"id":"2594294507","title":"Biohaven Shares Drop 10.4% After Co's Depression Drug Fails Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2594294507","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594294507?lang=en_us&edition=fundamental","pubTime":"2025-12-26 22:31","pubTimestamp":1766759507,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d018407bd33f27ba9ab8988ad29e6a0c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251226:nL4N3XW0HI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1093756325.SGD","LU1093756168.USD","BHVN","BK4139"],"gpt_icon":0},{"id":"1125440572","title":"Biohaven (BHVN.US) Plunges Nearly 13% Pre-Market as Depression Drug Fails Phase II Trial; Why is Wall Street Offering a Collective Defense?","url":"https://stock-news.laohu8.com/highlight/detail?id=1125440572","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125440572?lang=en_us&edition=fundamental","pubTime":"2025-12-26 21:44","pubTimestamp":1766756698,"startTime":"0","endTime":"0","summary":"Despite Wall Street analysts defending Biohaven Pharmaceutical Holding Co Ltd. (BHVN.US) in response to its Christmas Eve announcement, the biotech firm's stock still tumbled nearly 13% in pre-market...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d018407bd33f27ba9ab8988ad29e6a0c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BHVN","BK4139","LU1093756168.USD"],"gpt_icon":0},{"id":"2594299771","title":"US STOCKS-Wall St set for flat open in post-Christmas session","url":"https://stock-news.laohu8.com/highlight/detail?id=2594299771","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594299771?lang=en_us&edition=fundamental","pubTime":"2025-12-26 21:33","pubTimestamp":1766756011,"startTime":"0","endTime":"0","summary":"US STOCKS-Wall St set for flat open in post-Christmas sessionBiohaven falls after depression drug fails mid-stage trialFutures: Dow down 0.13%, S&P 500 off 0.05%, Nasdaq up 0.03%All three main indexes set for double-digit yearly gainsUpdates before markets openBy Sruthi Shankar and Shashwat Chauhan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251226:nL4N3XW0F5:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDS","IE0004086264.USD","LU2106854487.HKD","LU2048586759.USD","LU2237957902.USD","BK4533","LU0175139822.USD","LU0683600562.USD","LU1923623000.USD","LU1989772840.SGD","LU2087625088.SGD","IE000W1ABFV2.USD","NVD2.UK","SG9999015952.SGD","BK4605","IE00BD6J9T35.USD","LU0096362180.USD","LU0820561818.USD","LU2250418816.HKD","LU0267386448.USD","IE00BZ1G4Q59.USD","LU1992135399.USD","LU0109391861.USD","LU1718418525.SGD","LU2360106780.USD","LU2089985449.USD","IE00B19Z3581.USD","NVD","LU0965509101.SGD","LU0964807845.USD","LU0348723411.USD","LU1852331112.SGD","LU1951200564.SGD","LU2552382058.USD","IE00BKVL7J92.USD","LU0957791311.USD","LU0557290698.USD","LU1917777945.USD","LU1223082196.USD","LU1064131342.USD","LU1232071149.USD","NVDU","CPNG","LU0823414478.USD","LU1623119135.USD","LU1861215975.USD","LU2361044949.HKD","LU0203202063.USD","LU2125909247.SGD","LU1974910355.USD","LU1145028129.USD","LU2213496289.HKD","LU0942090050.USD","LU0787776722.HKD","LU2125909916.SGD","LU0211327993.USD","LU0943347566.SGD","IE00BKDWB100.SGD","IE00BJJMRY28.SGD","LU0187121727.USD","LU2360107168.USD","IE0002270589.USD","IE00BMPRXQ63.HKD","SG9999015945.SGD","BK4567","LU1935042488.USD","LU2322448957.HKD","LU1429558221.USD","LU2264538146.SGD","LU0072462426.USD","SG9999014567.USD","LU0345770308.USD","BK4575","LU2087621335.USD","LU1791710582.SGD","LU2505996681.GBP","IE00BJJMRX11.SGD","3NVD.UK","LU0444973449.USD","LU0476273544.USD","LU1037948897.HKD","LU1035775433.USD","LU2286300806.USD","LU2413666426.HKD","IE00BK4W5L77.USD","LU1983260115.SGD","LU2471134796.USD","IE00B5949003.HKD","BK4587","LU0511384066.AUD","LU0203345920.USD","LU1629891620.HKD","BK4554","LU2023251221.USD","BK4529","LU1935043536.SGD","LU2413666699.HKD","LU1815333072.USD","LU0081259029.USD","LU2242650005.HKD","IE0004445239.USD","LU0719512351.SGD","IE00BFSS8Q28.SGD","LU1674673691.USD","NVDD","IE00BWXC8680.SGD","LU1069344957.HKD","LU0353189680.USD","LU0154236417.USD","LU2506951792.HKD","BK4614","LU0345770993.USD","LU1868837300.USD","LU1261432733.SGD","LU2471134523.USD","LU0203201768.USD","IE00BYXW3230.USD","BK4548","LU2125909759.SGD","SG9999014542.SGD","IE00BK4W5M84.HKD","LU1720051108.HKD","LU1551013342.USD","LU2322448791.USD","LU1778281490.HKD","LU2249611893.SGD","LU2065170008.USD","LU0234572021.USD","LU2491050154.USD","SG9999015978.USD","LU1548497426.USD","LU0345768740.USD","LU0057025933.USD","IE00BMPRXN33.USD","LU0823421333.USD","LU0985320562.USD","LU1244550221.USD","SG9999014906.USD","LU0127658192.USD","LU0061474705.USD","LU0308772762.SGD","SG9999017495.SGD","LU0316494557.USD","LU0390134368.USD","LU1093756168.USD","LU1084165304.USD","LU2746668974.SGD","IE00BFSS7M15.SGD","SG9999015358.SGD","LU1280957306.USD","LU2211815571.USD","LU0170899867.USD","LU1791710400.SGD","LU0861579265.USD","LU0820562030.AUD","LU2860962120.EUR","LU1868836591.USD","SGXZ31699556.SGD","LU0788109477.HKD","LU1923622614.USD","LU0157215616.USD","SG9999015341.SGD","LU0289960550.SGD","LU1037948541.HKD","LU1242518931.SGD","LU2430703251.USD","LU0353189763.USD","LU0786609619.USD","LU0056508442.USD","LU0238689110.USD","LU1988902786.USD","LU0225283273.USD","LU2244417387.USD","LU2065169927.USD","IE00BJTD4V19.USD","LU2089284900.SGD","LU2491050071.SGD","LU1721428933.USD","LU0215105999.USD","LU0158827948.USD","IE00B7SZLL34.SGD",".SPX","LU0289739343.SGD","LU1989772923.USD","LU0203347892.USD","LU2456880835.USD","SG9999001424.SGD","LU0965509010.AUD","LU2023250330.USD","LU2592432038.USD","LU1551013425.SGD","SG9999014914.USD","LU0354030438.USD","NVDY","BK4543","LU0472753341.HKD","LU0689626769.HKD","SG9999002224.SGD","LU1366192091.USD","BK4585","LU0053666078.USD","LU2125154935.USD","LU2403377893.USD","LU1712237335.SGD","LU2237438978.USD","HK0000320223.HKD","LU0347712357.USD","LU0198837287.USD","LU0210528500.USD","LU1496350171.SGD","LU1861220033.SGD","LU2381873111.SGD","LU1242518857.USD","LU0889566641.SGD","LU0708994859.HKD","LU0444971666.USD","LU0417517546.SGD","LU0642271901.SGD","LU0823434740.USD","LU0528227936.USD","LU1435385759.SGD","LU2543165471.USD","LU1066051811.HKD","LU2357125470.USD","LU0345769128.USD","LU0494093205.USD","BK4592","IE0009356076.USD","BK4527","LU0672654240.SGD","LU0289961442.SGD","LU0029864427.USD","LU0080751232.USD","LU0868494617.USD","LU2168564149.EUR","LU2083900584.USD","LU2054465674.USD","LU2168564222.USD","BK4608","LU0124676726.USD","LU0128525929.USD","LU2417539215.USD","LU1267930490.SGD","LU1267930573.SGD","LU1116320737.USD","LU2326559502.SGD","IE0034235295.USD","HK0000320264.USD","LU2294711713.HKD","BK4139","LU0957808578.USD","LU0061475181.USD","BK4598","IE000ITXATA3.USD","LU2896262040.SGD","IE00BDCRKT87.USD","LU0965509283.SGD","NVDS.UK","IE00B4YYXB79.USD","LU0006306889.USD","LU1244550577.SGD","IE0005OL40V9.USD","LU2552382132.HKD","LU0234570918.USD","LU2125154778.USD","LU2236285917.USD","NVDX","IE0001KFT4U8.USD","LU2471134952.CNY","IE00B775H168.HKD","IE00BMPRXR70.SGD","BK4566","LU0106261372.USD","LU2290526834.HKD","LU2361044865.SGD","BHVN","LU2458330243.SGD","SGXZ23171101.USD","IE00BQXX3F31.USD","LU1267930730.SGD","LU1935042991.SGD","LU0708995401.HKD","SGXZ51526630.SGD","IE00B19Z8X17.USD","LU0256863811.USD","LU2505996509.AUD","LU1223082519.USD","IE0004091025.USD","LU0889565833.HKD","LU2065171402.SGD","LU2756315318.SGD","LU1989764664.SGD","LU1992135472.HKD","LU1699723380.USD","LU0082616367.USD","LU2191332357.HKD","LU0724617625.USD","LU2487616109.SGD","SG9999014898.SGD","LU1366333091.USD","LU2746668461.USD","LU1815336760.USD","IE0034235303.USD","SG9999004303.SGD","LU2462157665.USD","LU1821325948.USD","LU0868494708.USD","LU2168563687.JPY","LU2265009873.SGD","BK4551","LU1720051017.SGD","IE00B1XK9C88.USD","LU1814569148.SGD","SG9999018857.SGD","LU1803068979.SGD","SG9999014880.SGD","LU2065171311.SGD","LU2473716301.USD","BK4220","LU2430703095.HKD","LU0345768153.USD","LU2092627202.USD","BK4588","LU1951198990.SGD","BK4581","LU2111349929.HKD","IE00B19Z8W00.USD","LU0265550359.USD","LU1323610961.USD","LU0323591593.USD","SGXZ81514606.USD","BK4579","BK4141","LU2077746001.SGD","LU1989764748.USD","LU0274383776.USD","GB00BDT5M118.USD","IE00BQXX3C00.GBP","LU1116320901.HKD","LU0077335932.USD","IE00BJTD4N35.SGD","LU0320765059.SGD","LU1066051498.USD","LU1934455194.USD","IE00B4JS1V06.HKD","LU0882574139.USD","LU2420271590.USD","LU2108987350.USD","LU1674673428.USD","LU0094547139.USD","LU2360032135.SGD","LU1804176565.USD","IE00BHPRN162.USD","LU2271345857.HKD","LU0265550946.USD","BK4512","LU2242649171.HKD","IE00BZ199S13.USD","IE0003U64NQ7.SGD","SG9999000418.SGD","LU1633808545.USD","LU0079474960.USD","LU2168564495.EUR","LU0210533765.USD","IE00BJLML261.HKD","LU0210536198.USD","LU1244550494.USD","SNVD.UK","BK4532","IE00BKPKM429.USD","LU2125909593.SGD","LU2247934214.USD","LU0640476718.USD","LU1066051225.USD","SG9999015986.USD","IE00B7KXQ091.USD","LU2361045086.USD","BK4550","IE00B1BXHZ80.USD","LU1934455277.USD","NVIW.SI","LU0276348264.USD","LU0823414551.USD","LU0354030511.USD","SG9999018865.SGD","LU0792757196.USD","IE000KEQY171.SGD","IE00B3SWFQ91.USD","LU2272731782.SGD","LU0342679015.USD","LU2237957811.SGD","LU2471134879.HKD","BK4553","IE00BDRTCR15.USD","LU0061474960.USD","LU2461242641.AUD","LU0158827781.USD","LU1066053197.SGD","LU1839511570.USD","LU2452424414.USD","LU2092937148.SGD","LU1934455863.HKD","BK4017","LU2931357623.SGD","LU2272731600.USD","LU2602419157.SGD","LU2458330169.SGD","LU0048584097.USD","LU1935042215.USD","NVD3.UK","IE00BN29S564.USD","LU1127390331.HKD","IE00B19Z3B42.SGD","LU2023250504.SGD","LU1093756325.SGD","SG9999014559.SGD","LU2463028550.USD","IE0034235188.USD","LU0266013472.USD","LU1119994496.HKD","LU2430703178.SGD","LU0097036916.USD","LU2750360997.AUD","LU2089283258.USD","LU0979878070.USD","LU0310799852.SGD","LU1868836914.USD","LU1868836757.USD","BK4534","IE0004445015.USD","LU0069063385.USD","LU0109392836.USD","LU0823421416.USD","LU1316542783.SGD","LU1267930813.SGD","LU1923622291.USD","IE000YTNTUN2.SGD","SGXZ99366536.SGD","LU0251132253.USD","BK4503","BK4122","LU1861127337.USD","LU1914381329.SGD","BK4612","IE0009G5SDU7.USD","LU0070217475.USD","LU1571399168.USD","LU2433249047.HKD","LU2168564065.EUR","2NVD.UK","LU2357305700.SGD","LU0823434583.USD","LU2750360641.GBP","IE00BQXX3D17.EUR","LU1496350502.SGD","LU0107464264.USD","LU0256863902.USD","LU2097344431.USD","LU2097344357.USD","LU0310800379.SGD","LU0965508806.USD","LU2756315664.SGD","IE00B19Z9505.USD","LU0466842654.USD","LU0345769631.USD","LU0096364046.USD","LU2028103732.USD","LU1642822529.SGD","LU2272731865.HKD","BK4549","SG9999014575.USD","LU2552382215.SGD","IE00B3M56506.USD","LU0211328371.USD","LU1868837136.USD","LU0689472784.USD","LU0820561909.HKD","SG9999002232.USD","LU1223083913.SGD","LU1935043023.USD","HK0000306685.HKD","LU2491049909.HKD","HK0000306701.USD","LU2063271972.USD"],"gpt_icon":1},{"id":"2594229975","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2594229975","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594229975?lang=en_us&edition=fundamental","pubTime":"2025-12-26 21:29","pubTimestamp":1766755796,"startTime":"0","endTime":"0","summary":"Health care stocks were declining pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF  0.1% lower and the iShares Biotechnology ETF  down 0.4%.Biohaven  shares were down more than 11% after the company said the phase 2 study evaluating BHV-7000 for the treatment of major depressive disorder failed to meet its primary endpoint.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","BK4581","BK4585","BK4588","LU1093756325.SGD","XBI","LU1093756168.USD","XLV","STT","LABU","FDN","BK4139","BHVN"],"gpt_icon":0},{"id":"2594990292","title":"Biohaven Misses The Mark In Depression Trial, Stock Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2594990292","media":"Benzinga_recent_news","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594990292?lang=en_us&edition=fundamental","pubTime":"2025-12-26 21:20","pubTimestamp":1766755200,"startTime":"0","endTime":"0","summary":"Biohaven's Phase 2 study with BHV-7000 in MDD did not meet its primary endpoint of reducing depressive symptoms in comparison to placebo.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/26/Medical-Research.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/26/Medical-Research.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/12/49592343/biohaven-misses-the-mark-in-depression-trial-stock-falls","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/12/49592343/biohaven-misses-the-mark-in-depression-trial-stock-falls","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU1093756168.USD","LU1093756325.SGD","BK4139","XENE","BHVN"],"gpt_icon":0},{"id":"2594494299","title":"Biohaven, Omeros And Other Big Stocks Moving Lower In Friday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2594494299","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594494299?lang=en_us&edition=fundamental","pubTime":"2025-12-26 21:03","pubTimestamp":1766754180,"startTime":"0","endTime":"0","summary":"U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Friday.Shares of Biohaven Ltd  fell sharply in pre-market trading after the company reported that its Phase 2 depression drug trial missed its primary endpoint.The biopharmaceutical company announced BHV-7000, an investigational drug for major depressive disorder, failed to achieve a reduction in depressive symptoms versus placebo in the six-week study, measured by the Montgomery sberg Depression Rating Scale.Biohaven shares dipped 14.3% to $9.27 in pre-market trading.Here are some other stocks moving lower in pre-market trading.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/26/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/26/Display-Of-Stock-Market-Quotes.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/25/12/49592180/biohaven-omeros-and-other-big-stocks-moving-lower-in-fridays-pre-market-session","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/12/49592180/biohaven-omeros-and-other-big-stocks-moving-lower-in-fridays-pre-market-session","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4139","LU1093756168.USD","OMER","BK4007","LU1093756325.SGD","BHVN"],"gpt_icon":0},{"id":"2594964272","title":"These Stocks Are Moving the Most Today: Nvidia, Micron, Nike, Tesla, Biohaven, Coupang, and More -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2594964272","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594964272?lang=en_us&edition=fundamental","pubTime":"2025-12-26 20:39","pubTimestamp":1766752740,"startTime":"0","endTime":"0","summary":"Stock futures edged down in premarket trading Friday as U.S. equities exchanges reopened following the Christmas holiday. Trading volume likely will be light with much of Wall Street out of the office.Nvidia climbed 0.6% in premarket trading. The chip maker entered into a nonexclusive agreement to license technology from Groq, an artificial-intelligence chip start-up, Groq announced on Christmas Eve. Both Groq's founder and president will leave the company and join Nvidia alongside other engineering talent. It isn't clear if Nvidia is taking an equity stake in the start-up.Micron Technology jumped 1.5% in the premarket session. The memory chip maker has finished 2025 on a high note, handily beating earnings expectations earlier this month. Shares climbed 3.8% to a record closing high of $286.68 on Wednesday.Nike stock rose 0.4%. The athletic apparel company was the top stock in the S&P 500 on Wednesday, climbing 4.6% after a regulatory disclosure showed that Apple CEO Tim Cook bought n","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125909916.SGD","LU1127390331.HKD","LU2471134952.CNY","IE00B775H168.HKD","LU1116320901.HKD","LU0354030438.USD","LU2168564065.EUR","LU1951198990.SGD","IE000YTNTUN2.SGD","IE00B1BXHZ80.USD","LU1242518931.SGD","BK4516","LU2552382215.SGD","LU0943347566.SGD","IE0034235295.USD","IE00B19Z9505.USD","LU1267930730.SGD","LU0056508442.USD","LU0823421333.USD","LU0158827781.USD","IE00BZ199S13.USD","LU0127658192.USD","LU2473716301.USD","SGXZ99366536.SGD","LU1839511570.USD","LU2272731865.HKD","IE00BJTD4V19.USD","LU0889566641.SGD","IE00BMPRXR70.SGD","LU0072462426.USD","LU2433249047.HKD","IE00B4YYXB79.USD","BK4614","LU1803068979.SGD","LU1261432733.SGD","LU0094547139.USD","LU0823414551.USD","LU2506951792.HKD","LU2357305700.SGD","LU2265009873.SGD","IE0009356076.USD","LU0823411888.USD","IE00B1XK9C88.USD","LU1366333091.USD","LU1066051811.HKD","LU0077335932.USD","SG9999004303.SGD","BK4585","IE00BMPRXN33.USD","LU1861127337.USD","SGXZ31699556.SGD","LU0210528500.USD","IE000ITXATA3.USD","LU1951200564.SGD","IE00BKDWB100.SGD","BK4592","LU0476273544.USD","IE00BJJMRX11.SGD","LU0889565833.HKD","LU0203202063.USD","LU2125909759.SGD","LU0528227936.USD","LU0353189763.USD","LU1551013425.SGD","LU1267930490.SGD","LU1674673691.USD","IE000KEQY171.SGD","SGXZ23171101.USD","LU0823434740.USD","BK4554","LU1496350502.SGD","LU1868836757.USD","LU0353189680.USD","NVD3.UK","IE00BDCRKT87.USD","LU2290526834.HKD","LU1804176565.USD","LU2361044865.SGD","SG9999014542.SGD","LU2092627202.USD","LU2168563687.JPY","LU2249611893.SGD","LU1791710400.SGD","IE00B19Z3581.USD","LU0053666078.USD","LU0096362180.USD","LU1989772840.SGD","NVDA","SG9999014914.USD","LU0081259029.USD","3NVD.UK","LU0157215616.USD","LU1923622614.USD","LU2896262040.SGD","LU2065171402.SGD","LU1435385759.SGD","LU0868494617.USD","LU1923622291.USD","LU0289961442.SGD","LU1917777945.USD","LU0708994859.HKD","LU0266013472.USD","LU2125154778.USD","LU0965509283.SGD","SG9999015978.USD","LU1712237335.SGD","LU0274383776.USD","LU2028103732.USD","LU1035775433.USD","LU0390134368.USD","LU2746668974.SGD","HK0000306701.USD","LU2360107168.USD","LU2458330243.SGD","LU1642822529.SGD","GB00BDT5M118.USD","LU2463028550.USD","LU0965508806.USD","LU1244550221.USD","IE00BJLML261.HKD","IE00BN29S564.USD","BK4579","LU1674673428.USD","LU0061475181.USD","IE00BK4W5L77.USD","LU1791710582.SGD","BK4141","LU0823414478.USD","LU2125909247.SGD","BK4529","LU2083900584.USD","BK4555","LU2023251221.USD","NVDY","LU1992135472.HKD","LU1989772923.USD","SGXZ51526630.SGD","LU0347712357.USD","IE00BFSS8Q28.SGD","IE00BWXC8680.SGD","LU1366192091.USD","LU1815336760.USD","IE00BKPKM429.USD","LU1116320737.USD","LU0345769631.USD","LU0029864427.USD","LU2430703251.USD","SG9999014575.USD","LU0109391861.USD","LU2087621335.USD","IE00BFXG0V08.USD","LU2023250504.SGD","LU1720051017.SGD","LU0786609619.USD","LU1778281490.HKD","LU1084165304.USD","LU0267386448.USD","LU0788109477.HKD","LU0106261372.USD","IE00B3SWFQ91.USD","BK4553","LU0642271901.SGD","LU2089284900.SGD","LU0345770993.USD","LU1934455277.USD","LU1267930573.SGD","LU1861220033.SGD","LU0234570918.USD","LU0979878070.USD","SNVD.UK","LU0861579265.USD","LU0957808578.USD","IE0004445239.USD","LU2097344431.USD","LU2125154935.USD","LU2361045086.USD","LU2236285917.USD","LU2552382132.HKD","LU2746668461.USD","LU0724617625.USD","MU","SG9999014559.SGD","LU2087625088.SGD","BK4598","IE00BD6J9T35.USD","LU0719512351.SGD","BK4561","BK4588","CPNG","LU1861215975.USD","LU1066051225.USD","LU1066053197.SGD","LU1718418525.SGD","LU2326559502.SGD","LU0417517546.SGD","LU0061474705.USD","SG9999014906.USD","SG9999017495.SGD","IE00BQXX3F31.USD","LU0957791311.USD","LU0265550946.USD","IE00B7KXQ091.USD","LU1699723380.USD","LU0511384066.AUD","LU1064131342.USD","LU1821325948.USD","LU0080751232.USD","LU0342679015.USD","LU2247934214.USD","LU0683600562.USD","LU2237957902.USD","LU0444971666.USD","HK0000320223.HKD","BK4604","LU0787776722.HKD","LU2250418816.HKD","IE0009G5SDU7.USD","IE00BJTD4N35.SGD","LU1934455863.HKD","LU1935043023.USD","NVDD","BK4587","LU2077746001.SGD","LU1629891620.HKD","NVIW.SI","LU0251132253.USD","LU2403377893.USD","LU0265550359.USD","IE00BK4W5M84.HKD","LU0308772762.SGD","IE00BDRTCR15.USD","BK4574","IE00BJJMRY28.SGD","LU1267930813.SGD","LU0323591593.USD","LU0256863902.USD","LU2242649171.HKD","NVDX","IE00BKVL7J92.USD","LU0823434583.USD","NVDS","LU2063271972.USD","LU0689472784.USD","LU0820561909.HKD","LU1069344957.HKD","LU0640476718.USD","LU0158827948.USD","LU2471134796.USD","LU1974910355.USD","LU0057025933.USD","LU0203347892.USD","LU1548497426.USD","LU1935042991.SGD","LU0472753341.HKD","LU2089283258.USD","LU0187121727.USD","LU0070217475.USD","LU2191332357.HKD","LU2213496289.HKD","LU2430703095.HKD","LU1934455194.USD","NVDS.UK","LU1551013342.USD","LU1935043536.SGD","LU2471134523.USD","LU2360106780.USD","LU2471134879.HKD","LU0965509010.AUD","LU1868836914.USD","LU2098885051.SGD","BK4608","LU1323610961.USD","LU0820562030.AUD","LU0823421416.USD","LU0203201768.USD","SG9999014567.USD","LU2272731782.SGD","LU1983260115.SGD","LU2462157665.USD","LU2237438978.USD","SG9999001424.SGD","LU2860962120.EUR","LU2092937148.SGD","LU2505996681.GBP","LU0310799852.SGD","LU1303367103.USD","LU2361044949.HKD","LU0557290698.USD","LU0079474960.USD","LU1868837136.USD","BK4567","LU0124676726.USD","IE00BYQQ9H92.USD","LU2168564495.EUR","LU2211815571.USD","LU2456880835.USD","LU0965509101.SGD","LU0238689110.USD","IE00BQXX3D17.EUR","LU0345768740.USD","LU2054465674.USD","LU2106854487.HKD","LU2272731600.USD","IE0004086264.USD","LU1242518857.USD","LU0107464264.USD","LU1037948541.HKD","LU2491050071.SGD","BK4581","LU2065169927.USD","LU0792757196.USD","LU1914381329.SGD","LU1992135399.USD","LU0348723411.USD","LU0109392836.USD","LU1244550494.USD","LU2413666426.HKD","LU0310800379.SGD","LU1868837300.USD","LU2461242641.AUD","LU2242650005.HKD","LU0061474960.USD","LU1145028129.USD","IE00BMPRXQ63.HKD","SG9999015952.SGD","SG9999000418.SGD","BK4220","LU0256863811.USD","SG9999014898.SGD","LU0097036916.USD","LU2750360997.AUD","SG9999002232.USD","LU2357125470.USD","BK4605","BK4575","IE00BSNM7G36.USD","BK4548","LU0672654240.SGD","BK4532","LU0354030511.USD","BK4533","LU1496350171.SGD","LU2602419157.SGD","BK4511","BK4146","LU2125909593.SGD","LU1935042215.USD","IE00BHPRN162.USD","LU2023250330.USD","LU2756315318.SGD","IE0034235303.USD","LU0345770308.USD","LU2271345857.HKD","LU2048586759.USD","LU0175139822.USD","LU2264538146.SGD","BK4099","LU0345769128.USD","LU1633808545.USD","LU2592432038.USD","LU1852331112.SGD","LU0082616367.USD","IE0004091025.USD","LU2931357623.SGD","BK4549","IE00B19Z3B42.SGD","LU0289960550.SGD","IE00B19Z8X17.USD","LU2430703178.SGD","LU0128525929.USD","LU2452424414.USD","LU2505996509.AUD","LU2294711713.HKD","SG9999018865.SGD","LU0276348264.USD","IE00B7SZLL34.SGD","LU0882574139.USD","LU1868836591.USD","LU2491049909.HKD","IE0002270589.USD","BK4122","LU2756315664.SGD","BK4512","LU2168564222.USD","LU0444973449.USD","LU0689626769.HKD","LU0289739343.SGD","LU1429558221.USD","LU2322448791.USD","LU0006306889.USD","LU1244550577.SGD","BK4551","BK4527","LU1721428933.USD","IE00B3M56506.USD","LU0494093205.USD","SG9999018857.SGD","LU0210536198.USD","BK4543","SG9999014880.SGD","LU1316542783.SGD","IE00BYXW3230.USD","BK4612","LU2417539215.USD","NVD2.UK","IE0005OL40V9.USD","IE0003U64NQ7.SGD","LU0069063385.USD","LU1814569148.SGD","NVD","LU0234572021.USD","SGXZ81514606.USD","LU0225283273.USD","LU1623119135.USD","LU1861558580.USD","LU2097344357.USD","LU2237957811.SGD","LU1923623000.USD","LU0154236417.USD","LU0048584097.USD","LU1861559042.SGD","IE00BFSS7M15.SGD","LU0320765059.SGD","BK4139","LU2413666699.HKD","NVDU","2NVD.UK","LU0708995401.HKD","LU2487616109.SGD","LU0820561818.USD","SG9999015986.USD","IE0001KFT4U8.USD","SG9999002224.SGD","LU1093756325.SGD","BK4534","LU1093756168.USD","LU1571399168.USD","BHVN","LU1232071149.USD","LU1037948897.HKD","LU1720051108.HKD","TSYW.SI","LU2286300806.USD","LU0985320562.USD","LU2111349929.HKD","IE00B5949003.HKD","LU2244417387.USD","LU0215105999.USD","LU2322448957.HKD","LU0211327993.USD","LU1989764664.SGD","IE000W1ABFV2.USD","LU2381873111.SGD","LU1935042488.USD","SG9999015945.SGD","IE00B4JS1V06.HKD","IE0034235188.USD","LU2360032135.SGD","LU2168564149.EUR","LU1280957306.USD","LU2420271590.USD","LU2543165471.USD","LU0942090050.USD","LU2552382058.USD","HK0000320264.USD","LU0466842654.USD","LU1119994496.HKD","LU1989764748.USD","LU0211328371.USD","HK0000306685.HKD","LU0210533765.USD","LU2065171311.SGD","LU0345768153.USD","LU0203345920.USD","SG9999015358.SGD","LU1815333072.USD","SG9999015341.SGD","BK4566","LU0316494557.USD","LU1066051498.USD","LU0868494708.USD","IE00B19Z8W00.USD","IE00BQXX3C00.GBP","IE00BZ1G4Q59.USD","LU2108987350.USD","LU1988902786.USD","LU0964807845.USD","LU2491050154.USD","LU2065170008.USD","LU0198837287.USD","LU2458330169.SGD","LU0096364046.USD","LU0170899867.USD","BK4503","BK4550","LU2750360641.GBP","BK4558","LU2089985449.USD","IE0004445015.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.biohaven.com","stockEarnings":[{"period":"1week","weight":0.1544},{"period":"1month","weight":0.3105},{"period":"3month","weight":-0.1711},{"period":"6month","weight":0.0193},{"period":"1year","weight":-0.6607},{"period":"ytd","weight":0.2188}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0173},{"period":"6month","weight":0.0814},{"period":"1year","weight":0.1361},{"period":"ytd","weight":0.0104}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Biohaven Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with debilitating neurological and neuropsychiatric diseases in the United States. The company's pipeline products include BHV-7000, a potassium channel activator for the treatment of focal epilepsy; BHV-7010, a Kv7 channel modulator for the treatment of different neurological diseases; Troriluzole, a tripeptide prodrug that is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500, a low-trapping glutamate N-methyl-D-aspartate receptor antagonist for neuropathic pain; and Verdiperstat, an oral myeloperoxidase inhibitor, which is in Phase 3 clinical trial for the treatment of neurodegenerative diseases. It also offers Taldefgrobep Alfa, an anti-myostatin adnectin, which is in Phase 3 clinical trial for the treatment of spinal muscle atrophy; and BHV-1100 that is in Phase 1a/1b clinical trial for multiple myeloma patients. The company was formerly known as Biohaven Research Ltd and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut. Biohaven Ltd. is a subsidiary of Biohaven Pharmaceutical Holding Company Ltd.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.090844},{"month":2,"riseRate":0.25,"avgChangeRate":-0.026088},{"month":3,"riseRate":0.25,"avgChangeRate":-0.102404},{"month":4,"riseRate":0.5,"avgChangeRate":0.0146},{"month":5,"riseRate":0.625,"avgChangeRate":0.144142},{"month":6,"riseRate":0.555556,"avgChangeRate":0.056007},{"month":7,"riseRate":0.555556,"avgChangeRate":0.010799},{"month":8,"riseRate":0.666667,"avgChangeRate":0.043364},{"month":9,"riseRate":0.777778,"avgChangeRate":0.09598},{"month":10,"riseRate":0.555556,"avgChangeRate":-0.072057},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.042561},{"month":12,"riseRate":0.555556,"avgChangeRate":0.054983}],"exchange":"NYSE","name":"Biohaven Pharmaceutical Holding Co Ltd.","nameEN":"Biohaven Pharmaceutical Holding Co Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biohaven Pharmaceutical Holding Co Ltd.(BHVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biohaven Pharmaceutical Holding Co Ltd.(BHVN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biohaven Pharmaceutical Holding Co Ltd.,BHVN,Biohaven Pharmaceutical Holding Co Ltd.股票,Biohaven Pharmaceutical Holding Co Ltd.股票老虎,Biohaven Pharmaceutical Holding Co Ltd.股票老虎国际,Biohaven Pharmaceutical Holding Co Ltd.行情,Biohaven Pharmaceutical Holding Co Ltd.股票行情,Biohaven Pharmaceutical Holding Co Ltd.股价,Biohaven Pharmaceutical Holding Co Ltd.股市,Biohaven Pharmaceutical Holding Co Ltd.股票价格,Biohaven Pharmaceutical Holding Co Ltd.股票交易,Biohaven Pharmaceutical Holding Co Ltd.股票购买,Biohaven Pharmaceutical Holding Co Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biohaven Pharmaceutical Holding Co Ltd.(BHVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biohaven Pharmaceutical Holding Co Ltd.(BHVN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}